Topics
November/December 2013 | 5q
With Carl C. Awh, MD
Dr. Awh practices at Tennessee Retina in Nashville.
October 16, 2026
Alvotech and Advanz Pharma Submit European Application for First Proposed Eylea 8 mg Biosimilar
FDA Approves Genentech's Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
October 15, 2026
Study Finds Rising Demand for Emergency Ophthalmology Consultations Across US Academic Centers
Eclipse Life Sciences Reports Positive Phase 2 Results for EC-104 in DME
October 2026 Insert
Editorially Independent Content, Supported With Advertising From Asetllas
Editorially independent supported by Abbvie and Regenxbio
Free Print Subscription
Email Newsletter
Conference Calendar
